TD001
TD001-101
Phase 2 small_molecule active
Quick answer
TD001 for Metastatic castration-resistant prostate cancer is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ology Bioservices Ireland LTD
- Indication
- Metastatic castration-resistant prostate cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active